Modulation of pituitary insulin-like growth factor-l bindings in rats bearing somatomammotrophic tumors

Journal of Endocrinological Investigation - Tập 16 - Trang 189-194 - 2014
K. Matsuo1, S. Yamashita2, H. Namba2, M. Niwa3, S. Harakawa1, M. Izumi1, S. Nagataki1
1The First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
2Department of Cell Physiology, Atomic Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan
3the Second Department of Pharmacology, Nagasaki University School of Medicine, Nagasaki, Japan

Tóm tắt

To clarify the hormonal regulation of pituitary insulin-like growth factor-l (IGF-I) bindings, we examined the continuous effect of growth hormone (GH) on [125I] IGF-I binding sites, using rats bearing transplantable GH-secreting rat pituitary tumor cells. A total of 24 female Wistar-Furth rats (4-week old) was divided into four groups (n=6). The first group rats were control (C). The second group rats were injected subcutaneously with 3×106 GH3 pituitary tumor cells (GH). The third group rats were thyroidectomized (Tx) and the fourth were dual-treated (GHTx). The brain, pituitary gland, liver, and kidney were immediately subjected to quantitative receptor autoradiography after a 4-week treatment period. Using kinetic experiments, GH rats had higher Bmax values of specific [125I] IGF-I binding sites in the anterior pituitary gland and Tx rats had lower Bmax values than control rats. Two-way analysis of variance among the 4 groups was examined. The effects of both GH and Tx treatment on [125l] IGF-I binding Bmax were observed only in the anterior pituitary gland and not in the other tissues examined. There were no differences in the Kd values of the binding sites. These data indicate that continuous GH excess selectively up-regulates the number of pituitary IGF-I binding sites in vivo, and that this may play a role in feedback regulation of the GH-IGF-I axis.

Tài liệu tham khảo

Froesch E.R., Schmidt C.H., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu. Rev. Physiol. 47: 443, 1985. Daughaday W. H., Rotwein P. Insulin-like growth factors I and II peptides. Messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr. Rev. 10: 68, 1989. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L, Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1982. Brazeau P., Guillemin R., Ling N., Van Wyk J.J., Humbel R. Inhibition by somatomedins of growth hormone secretion stimulated by hypothalamic growth hormone releasing factor (somatocrinin GRF) or the synthetic-peptide hpGRF. C. R. Acad. Sci. [D] (Paris) 295: 651, 1982. Tannenbaum G.S., Guyda J.H., Posner B.I. Insulin-like growth factors: a role in growth hormone negative feedback, body weight-regulation via brain. Science 220: 77, 1983. Abe H., Molitch M.E., Van Wyk J.J., Underwood LE. Human growth hormone, somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 773: 1319, 1983. Yamashita S., Melmed S. Insulin-like growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J.Clin. Invest. 79: 449, 1987. Yamashita S., Melmed S. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion, messenger ribonucleic acid levels. Endocrinology 118: 176, 1986. Morita S., Yamashita S., Melmed S. Insulin-like growth factor I action on rat anterior pituitary cells: effects of intracellular messengers on growth hormone secretion and messenger ribonucleic acid levels. Endocrinology 121: 2000, 1987. Goodyear C.G., Stephano L.D., Lai W.H., Guyda H.J., Posner B.I. Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus, and brain. Endocrinology 114: 1187, 1984. Rosenfeld R.G., Ceda G., Wilson D.M., Dollar L.A., Hoffman A.R. Characterization of high affinity receptors for insulinlike growth factors I and II on rat anterior pituitary cells. Endocrinology 114: 1571, 1984. Rosenfeld R.G., Ceda G., Cutler C.W., Dollar L.A., Hoffman A.R. Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells. Endocrinology 117: 2008, 1985. Ceda G.P., Hoffman A.R., Silverberg G.D., Wilson D.M., Rosenfeld R.G. Regulation of GH release from cultured human pituitary adenomas by somatomedins and insulin. J. Clin. Endocrinol. Metab. 60: 1204, 1985. Yamashita S., Weiss M., Melmed S. Insulin-like growth factor I regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumor cells. J. Clin. Endocrinol. Metab. 63: 730, 1986. Jacobs S., Cook S., Svoboda M.E., Van Wyk J.J. Interaction of the monoclonal antibodies IR-I and IR-3 with insulin and somatomedin-C receptors. Endocrinology 118: 223, 1986. Fagin J.A., Fernandez Mejia C, Melmed S. Pituitary insulin-like growth factor I gene expression: regulation by triiodothyronine and growth hormone. Endocrinology 125: 2335, 1989. Matsuo K., Yamashita S., Niwa M., Kurihara M., Harakawa S., Izumi M., Nagataki S., Melmed S. Thyroid hormone regulates rat pituitary insulin-like growth factor (IGF-I) receptors. Endocrinology 126: 550, 1990. Melmed S., Yamashita S. Insulin-like growth factor-I action on hypothyroid rat pituitary cells: suppression of triiodothyronine-induced growth hormone secretion and mRNA levels. Endocrinology 118: 1483, 1986. Matsuo K., Niwa M., Kurihara M., Shigematsu K., Yamashita S., Ozaki M., Nagataki S. Receptor autoradiographic analysis of insulin-like growth factor I (IGF-I) binding sites in rat forebrain and pituitary gland. Cell. Mol. Neurobiol. 9: 357, 1989. Harakawa S., Yamashita S., Tobinaga T., Matsuo K., Hirayu H., Izumi M., Nagataki S., Melmed S. In vivo regulation of hepatic insulin-like growth factor-I messenger ribonucleic acids with thyroid hormone. Endocrinol. Japon. 37: 205, 1990. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220, 1980. Maiter D., Underwood L.D., Maes M., Davenport M.L., Ketelslegers J.M. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/Insulin-like growth factor I and level of GH receptors in hypophysectomized rats. Endocrinology 123: 1053, 1988. Yamashita S., Slanina S., Kado H., Melmed S. Autoregulation of pituitary growth hormone mRNA levels in rats bearing transplantable mamosommatotrophic pituitary tumors. Endocrinology 118: 915, 1986. Rosenfeld R.G., Dollar L.A. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayer: Regulation of receptor concentration by SMC/IGF-I and insulin. J. Clin. Endocrinol. Metab. 55: 434, 1982. Adashi E.Y., Reshik C.E., Hernandez E.R., Svoboda M.D., Van Wyk J.J. In vivo regulation of granulosa cell somatomedin C/insulin-like growth factor I receptors. Endocrinology 122: 1383, 1988. Lin T., Blaisdell J., Haskeel J.F. Hormonal regulation of type I insulin-like growth factor of Leydig cells in hypophysectomized rats. Endocrinology 123: 134, 1988. Dehoff M.H., Elgin R. G., Collier F.J., Clemmons D.R. Both type I and II insulin-like growth factor receptor binding increase during lactogenesis in bovine mam mary tissue. Endocrinology 122: 2412, 1988. Yamasaki H., Prager D., Gebremedhin S., Melmed S. Insulin-like growth factor-I (IGF-I) attenuation of growth hormone is enhanced by overexpression of pituitary IGF-I receptors. Mol. Endocrinol. 5: 890, 1991. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz DP., Dorsa D.M., Baskin D.G. Characterization of insulin-like growth factor I receptors in the medium eminence of the brain and their modulation by blood restriction. Endocrinology 122: 1940, 1988. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz D.P., Dorsa D.M., Baskin D.G. Localization of binding sites for insulin-like growth factor I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res. 444: 205, 1988. Lesniak M.A., Hill J.M., Kiess W., Rojeski M., Pert C.B., Roth J. Receptors for insulin-like growth factors I and II: Autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 123: 2089, 1988. Ceda G.P., Fielder P.J., Donovan S.H., Rosenfeld R.G., Hoffman A.R. Regulation of insulin-like growth factor-binding protein expression by thyroid hormone in rat GH3 pituitary tumor cells. Endocrinology 130: 1483, 1992. Nissley S.P., Rechler M.M. Insulin-like growth factors; biosynthesis, receptors, and carrier proteins. In: Hormonal Proteins and Peptides. Vol XII. Academic Press, Inc. New York 1984, p. 127. Tollefsen S.E., Sadow J.L., Rotwein. Coordinate expression of insulin-like growth factor-Il and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. USA 86: 1543, 1989. Tollefsen S.E., Lajara E.R., McCuscker R.H., Clemmens D.R., Potwein P. Insulin-like growth factors (IGF) in muscle development. J. Biol. Chem. 264: 13810, 1989. Rosenthal S.M., Brunetti A., Brown E.J., Mamula P.W., Goldfine I.D. Regulation of insulin-like growth factor-I receptor expression during muscle cell differentiation. J. Clin. Invest. 87: 1212, 1991.